COCP - CIK 0001412486
The table below shows Cocrystal Pharma, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | - | - | - | - | - | $18.14M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets | $5.94M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $8.78M |
| $6.76M |
| $8.83M |
| $14.26M |
| $19.66M |
| Property, plant & equipment | $81.00K | $106.00K | $107.00K | $127.00K | $181.00K | $211.00K |
| Goodwill | - | - | - | - | - | - |
| Total assets | $7.43M | $10.45M | $8.51M | $10.66M | $16.23M | $21.57M |
| Accounts payable | $1.37M | $745.00K | $856.00K | $808.00K | $859.00K | $1.74M |
| Total current liabilities | $2.23M | $1.52M | $1.83M | $1.93M | $1.95M | $2.65M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $3.31M | $2.78M | $3.17M | $3.35M | $3.53M | $4.18M |
| Retained earnings | -$344.55M | -$339.82M | -$337.77M | -$335.72M | -$330.15M | -$325.21M |
| Total equity | $4.12M | $7.67M | $5.33M | $7.30M | $12.70M | $17.39M |